XML 71 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock units issued and compensation expense
The following table summarizes RSUs issued and the compensation expense recorded for the years ended December 31, 2019, 2018, and 2017:
 
 
RSUs (a)
 
Weighted Average Fair Value
 
Expense
(Dollars in thousands, except per unit)
 
 
 
2019
 
2018
 
2017
Directors:
 
 
 
 
 
 
 
 
 
 
2016
 
109,998

 
$
7.00

 
$

 
$

 
$
257

2017
 
56,203

 
13.70

 

 
179

 
641

2018
 
43,821

 
20.54

 
280

 
511

 

2019
 
14,211

 
25.33

 
240

 

 

Employees:
 
 
 
 
 
 
 
 
 
 
2014
 
190,832

 
25.21

 

 

 
295

2015
 
239,679

 
16.53

 

 
193

 
498

2016
 
536,773

 
7.09

 
290

 
835

 
909

2017
 
286,251

 
13.70

 
832

 
910

 
1,325

2018
 
242,791

 
19.93

 
1,208

 
1,546

 

2019
 
270,864

 
22.25

 
1,620

 

 

Total
 
 

 
 

 
$
4,470

 
$
4,174

 
$
3,925

(a)
Represents number of awards originally issued.
Schedule of restricted stock unit activity
RSU activity for the year ended December 31, 2019 was as follows:
 
 
Number of Shares
 
Weighted Average
Grant-Date
Fair Value
Non-vested at December 31, 2018
 
583,380

 
$
15.08

Granted
 
285,075

 
22.40

Vested
 
(348,572
)
 
13.38

Forfeited
 
(53,274
)
 
20.01

Non-vested at December 31, 2019
 
466,609

 
20.26


Schedule of Stock Appreciation Rights award activity
SARs activity for the year ended December 31, 2019 was as follows:
 
 
Number of Shares
 
Weighted Average Exercise Price
 
Aggregate Intrinsic Value (in millions) (b)
Outstanding, December 31, 2018
 
1,745,447

 
$
15.73

 
$
8.9

Granted
 
229,344

 
22.79

 
 
Exercised
 
(43,594
)
 
15.87

 
 
Forfeited/Expired
 
(22,977
)
 
26.94

 
 
Outstanding, December 31, 2019
 
1,908,220

 
16.44

 
13.0


(b)
Intrinsic value is defined as the difference between the current market value and the exercise price, for those SARs where the market price exceeds the exercise price.
Schedule of nonvested awards activity
The following table summarizes information concerning outstanding and exercisable SARs at December 31, 2019:
 
 
SARs Outstanding
 
SARs Exercisable
Range of exercisable prices
 
Vested
 
Non-vested
 
Weighted-Average Exercise Price per Share
 
Weighted-Average Remaining Contractual Life in Years
 
Number Exercisable
 
Weighted-Average Exercise Price per Share
$7.00 - $13.70
 
624,693

 
83,654

 
$
9.42

 
6.65
 
624,693

 
$
8.85

$16.53 - $22.70
 
584,950

 
361,000

 
19.45

 
6.60
 
584,950

 
18.23

$23.03 - $26.92
 
248,841

 
5,082

 
24.78

 
4.45
 
248,841

 
24.79

 
 
1,458,484

 
449,736

 
16.44

 
6.33
 
1,458,484

 
15.33


Stock Appreciation Rights (SARs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock appreciation rights valuation assumptions he fair value of each SAR grant was estimated on the grant date using a Black-Scholes pricing model with the following assumptions:
 
 
Risk-free Interest rate
 
Dividend Yield
 
Expected Life (Years)
 
Volatility
 
SAR Grant Price
 
Fair Value of SAR
March 2017 Grant
 
2.17
%
 
%
 
6.0
 
43.9
%
 
$
13.70

 
$
6.13

March 2018 Grant
 
2.69
%
 
%
 
6.0
 
44.6
%
 
19.80

 
9.16

July 2018 Grant
 
2.87
%
 
%
 
6.0
 
44.7
%
 
24.65

 
11.48

March 2019 Grant
 
2.52
%
 
%
 
6.0
 
46.2
%
 
22.51

 
10.62

July 2019 Grant
 
1.84
%
 
%
 
6.0
 
47.1
%
 
27.39

 
12.80


Schedule of weighted-average grant-date fair value of unvested options
Weighted-average grant date fair value of non-vested SARs for the year ended December 31, 2019 was as follows:
 
 
Number of Shares
 
Weighted-Average Grant Date Fair Value
Non-vested shares, December 31, 2018
 
467,478

 
$
6.65

Granted
 
229,344

 
10.75

Vested
 
(233,842
)
 
5.17

Forfeited
 
(13,244
)
 
12.80

Non-vested shares, December 31, 2019
 
449,736

 
9.32


Performance Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock appreciation rights valuation assumptions The fair value of PSUs granted was estimated on the grant date using a Monte Carlo pricing model with the following assumptions:
 
 
Risk-free Interest rate
 
Dividend Yield
 
Expected Life (Years)
 
Volatility
 
Fair Value of PSU
March 2017 Grant
 
1.54
%
 
%
 
2.83
 
34.2
%
 
$
17.05

March 2018 Grant
 
2.36
%
 
%
 
2.83
 
34.7
%
 
29.56

July 2018 Grant
 
2.69
%
 
%
 
2.42
 
33.1
%
 
39.06

March 2019 Grant
 
2.48
%
 
%
 
2.82
 
33.8
%
 
29.04

July 2019 Grant
 
1.75
%
 
%
 
2.50
 
34.3
%
 
40.07

August 2019 Grant
 
1.57
%
 
%
 
2.41
 
34.9
%
 
23.38


Schedule of weighted-average grant-date fair value of unvested options
A summary of the Company's non-vested PSU activity during the year ending December 31, 2019 was as follows:
 
 
Number of Shares
 
Weighted-Average Grant Date Fair Value
Non-vested shares, December 31, 2018
 
494,882


$
23.13

Granted
 
277,307

 
28.51

Forfeited
 
(70,391
)
 
26.23

Vested, not issued (c)
 
(236,214
)
 
17.05

Non-vested shares, December 31, 2019
 
465,584

 
28.95